AVX-15385-04251
6 vaccinations
9 coded responses
14 check-ins
8 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 350 / AL
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Dose 1 — Moderna
-
2021-01-26
Dose 2 — Moderna
-
2021-03-19
Registered in v-safe
-
2021-07-28
Survey response — 6 months, dose 2MedDRA: Cough, Pre-existing disease, Respiratory tract congestion, Syncope — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Fainting, congestion, cough, mucus, eczema flareMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-28
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-05
-
2021-08-14
Dose 3 — Pfizer-BioNTech
-
2021-08-17
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2021-11-13
Survey response — 3 months, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: LymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-11-13
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-15
-
2022-01-11
Dose 4 — Pfizer-BioNTech
-
2022-02-12
Survey response — 6 months, dose 3MedDRA: Pruritus, Syncope, Upper respiratory tract infection, Urticaria — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Lots of fainting still, have had URI, itching and hivesMedDRA releases: 2024-11 · check-in free text available
-
2022-02-12
Survey response — day 28, dose 4MedDRA: Lymphadenopathy, Pruritus, Urticaria — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Itching and hives, swollen lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2022-02-12
Report sent to call center — day 28, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-12
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-16
-
2022-04-16
Survey response — 3 months, dose 4MedDRA: Asthma, Cough, Infection, Rash, Syncope, Ventricular extrasystoles — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Premature ventricular contractions; infection with cough and asthma attack; rash; daily fainting episodesMedDRA releases: 2024-11 · check-in free text available
-
2022-07-12
Survey response — 6 months, dose 4MedDRA: Abdominal pain, Haematochezia, Neutrophilia, Productive cough, Secretion discharge, Sinusitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sinus infection; bloody stools; abdominal pain; still have cough with mucus; still having neutrophiliaMedDRA releases: 2024-11 · check-in free text available
-
2022-07-26
Dose 5 — Pfizer-BioNTech
-
2022-09-21
Dose 6 — Pfizer-BioNTech
-
2022-09-26
Health check-in — days 1–6 daily, dose 6Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2022-09-30
Health check-in — day 7, dose 6Feeling: Fair · Headache, Fatigue or tiredness, DiarrheaAdult check-in
-
2022-10-05
Survey response — day 14, dose 6MedDRA: Abdominal pain, Nausea — Feeling: FairFree text: Gastrointestinal-severe nausea and abdominal painMedDRA releases: 2024-11 · check-in free text available
- 2022-10-12
-
2022-10-21
Survey response — day 28, dose 6MedDRA: Lymphadenopathy, Streptococcal infection — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Strep with lymph node swellingMedDRA releases: 2024-11 · check-in free text available
- 2022-10-26
- 2022-12-21
-
2023-03-22
Survey response — 6 months, dose 6MedDRA: Complication associated with device, Foot fracture, Muscle strain, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-08-14 | Pfizer-BioNTech | No |
| 4 | 2022-01-11 | Pfizer-BioNTech | No |
| 5 | 2022-07-26 | Pfizer-BioNTech | No |
| 6 | 2022-09-21 | Pfizer-BioNTech | No |
Call center
4 call center cases
1 successful · 3 unsuccessful
VAERS report filed, before or during a call: 1
Free text
Release 9 — 6 months, dose 2
Symptoms: Fainting, congestion, cough, mucus, eczema flare
Release 10 — 3 months, dose 3
Symptoms: Lymphadenopathy
Release 11 — day 28, dose 4
Symptoms: Itching and hives, swollen lymph nodes
Release 11 — 6 months, dose 3
Symptoms: Lots of fainting still, have had URI, itching and hives
Release 11 — 3 months, dose 4
Symptoms: Premature ventricular contractions; infection with cough and asthma attack; rash; daily fainting episodes
Release 12 — 6 months, dose 4
Symptoms: Sinus infection; bloody stools; abdominal pain; still have cough with mucus; still having neutrophilia
Release 12 — day 14, dose 6
Symptoms: Gastrointestinal-severe nausea and abdominal pain
Release 12 — day 28, dose 6
Symptoms: Strep with lymph node swelling
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | · | · | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Complication associated with device | · | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Foot fracture | · | · | ✓ |
| SD | Haematochezia | · | · | ✓ |
| SD | Infection | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Muscle strain | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Neutrophilia | · | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pruritus | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Streptococcal infection | · | · | ✓ |
| SD | Syncope | ✓ | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SD | Ventricular extrasystoles | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release